Acute pericarditis as a primary presentation of COVID-19

The COVID-19 pandemic is a highly contagious viral illness which conventionally manifests primarily with respiratory symptoms. We report a case whose first manifestation of COVID-19 was pericarditis, in the absence of respiratory symptoms, without any serious complications. Cardiac involvement in various forms is possible in COVID-19. We present a case where pericarditis, in the absence of the classic COVID-19 signs or symptoms, is the only evident manifestation of the disease. This case highlights an atypical presentation of COVID-19 and the need for a high index of suspicion to allow early diagnosis and limit spread by isolation.

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  K. Davidson,et al.  COVID-19 in kidney transplant recipients , 2020, American Journal of Transplantation.

[3]  P. Bhargava,et al.  Cardiac Tamponade Secondary to COVID-19 , 2020, JACC: Case Reports.

[4]  P. Triggianese,et al.  The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 , 2020, Journal of Autoimmunity.

[5]  Jianfeng Zhang,et al.  Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis , 2020, Journal of medical virology.

[6]  Yaling Han Initial COVID-19 affecting cardiac patients in China , 2020, European heart journal.

[7]  U. Maggiore,et al.  COVID-19 in kidney transplant recipients , 2020, American Journal of Transplantation.

[8]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[9]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[10]  Yan Zhao,et al.  The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China , 2020, Clinical Immunology.

[11]  Fenglian Ma,et al.  Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin , 2020, European heart journal.

[12]  M. Imazio,et al.  Colchicine in Pericarditis. , 2017, European heart journal.

[13]  C. Desnues,et al.  Viral Communities Associated with Human Pericardial Fluids in Idiopathic Pericarditis , 2014, PloS one.

[14]  H. Kühl,et al.  Acute viral pericarditis without typical electrocardiographic changes assessed by cardiac magnetic resonance imaging. , 2009, European heart journal.

[15]  A. Bayés-Genís,et al.  Colchicine in Pericarditis A Mediterranean legacy from Before Christ ( BC ) revived in the 21 st century AD , 2017 .

[16]  P. Rautava,et al.  [Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis]. , 2014, Duodecim; laaketieteellinen aikakauskirja.